Growth Metrics

908 Devices (MASS) EBT Margin Growth (3y) (2023 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin Growth (3y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -305.00
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -9.00
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -222.00
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 923.00
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -480.00
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 2,114.00
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 1,391.00
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -176.00
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 329.00
10 908 Devices 314.43 Mn 202.69 Mn 6.88 Mn 4,281.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 4,281.00
Dec 31, 2025 10,833.00
Sep 30, 2025 -6,663.00
Jun 30, 2025 -2,556.00
Mar 31, 2025 2,612.00
Dec 31, 2024 -8,920.00
Sep 30, 2024 -12,057.00
Jun 30, 2024 2,447.00
Mar 31, 2024 -3,643.00
Dec 31, 2023 2,046.00
Sep 30, 2023 -2,479.00
Jun 30, 2023 -9,478.00
Mar 31, 2023 -5,699.00